Gigantism: Clinical Trials

8 trials for Gigantism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 1 terminated, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Not applicable1Unknown 1
Phase 21Completed 1
Phase 41Terminated 1

Follow Gigantism: new trials by email Literature Review of Gigantism trials Research Report on Gigantism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Debio 4126, Placebo - Acromegaly
Phase 3RecruitingDebiopharm International SA1192025-11-262026-10-23
Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess
Pegvisomant - Pituitary Disease
Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)122019-10-212025-11-06
Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Pasireotide LAR - Acromegaly
Phase 3CompletedNovartis Pharmaceuticals1232015-03-312019-12-10
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Educational Intervention - Pituitary Neoplasms, Prolactinoma
Not applicableUnknownUnity Health Toronto602014-02-012015-07-31
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
lanreotide - Acromegaly
Phase 4TerminatedSaint John's Cancer Institute42013-05-012021-09-30
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
Pasireotide LAR - Acromegaly, Pituitary Gigantism
Phase 2CompletedNovartis Pharmaceuticals332012-10-162019-09-16
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Acromegaly, Gigantism
RecruitingBarts & The London NHS Trust100002007-03-012026-05-20
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Tissue specimen collection, MRI - Panhypopituitarism, Gigantism/Acromegaly
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)20001997-04-212026-10-19

Narrower conditions

Acromegaly (6)  ·  Pituitary Neoplasms (4)  ·  Growth Disorders (2)  ·  Pituitary Diseases (2)  ·  Prolactinoma (2)  ·  ACTH-Secreting Pituitary Adenoma (1)  ·  Carcinogenesis (1)  ·  Combined Pituitary Hormone Deficiency (1)  ·  Congenital Abnormalities (1)  ·  Growth Hormone-Secreting Pituitary Adenoma (1)  ·  Pituitary ACTH Hypersecretion (1)  ·  Pituitary Adenoma, Familial Isolated (1)

Broader conditions

Bone Diseases (8)  ·  Bone Diseases, Developmental (8)  ·  Bone Diseases, Endocrine (8)  ·  Brain Diseases (8)  ·  Central Nervous System Diseases (8)  ·  Endocrine System Diseases (8)  ·  Hyperpituitarism (8)  ·  Hypothalamic Diseases (8)  ·  Musculoskeletal Diseases (8)  ·  Nervous System Diseases (8)  ·  Pituitary Diseases (6)  ·  Endocrine Gland Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Brain Neoplasms (4)

Interventions

pasireotide (2)  ·  Early Intervention, Educational (1)  ·  Tissue Banks (1)  ·  lanreotide (1)  ·  pegvisomant (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Novartis Pharmaceuticals (2)  ·  Barts & The London NHS Trust (1)  ·  Debiopharm International SA (1)  ·  Saint John's Cancer Institute (1)  ·  Unity Health Toronto (1)

Countries

United States (4)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Bulgaria (2)  ·  France (2)  ·  Hungary (2)  ·  Italy (2)  ·  Romania (2)  ·  Argentina (1)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  Colombia (1)  ·  Denmark (1)

Top investigators

Daniel F Kelly, MD (1)  ·  Deborah P Merke, M.D. (1)  ·  Karim A Calis, Pharm.D. (1)  ·  Marta Korbonits, MD PhD (1)  ·  Michael Cusimano, MD, PhD (1)

Results publications

PMID 19170709, PMID 19344074, PMID 21208107, PMID 22154461, PMID 24412141, PMID 25258026, PMID 27253664, PMID 27496264, PMID 29395172, PMID 30234410, PMID 32117045, PMID 32232325, PMID 32714280, PMID 36149413, PMID 40813536, PMID 41349930, PMID 41540017

NIH funding

2014 (1)